The TOPS Showdown in Degenerative Spondylolisthesis (opens in new tab)
Head-to-head, motion preserving TOPS System versus degenerative spondylolisthesis. 249 patients. randomized FDA trial.
Read the original articleHead-to-head, motion preserving TOPS System versus degenerative spondylolisthesis. 249 patients. randomized FDA trial.
Read the original article